INT178888

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.65
First Reported 2003
Last Reported 2011
Negated 0
Speculated 0
Reported most in Body
Documents 41
Total Number 41
Disease Relevance 38.66
Pain Relevance 2.51

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

mitochondrion (CHDH)
Anatomy Link Frequency
coronary artery 1
chest 1
body 1
CHDH (Homo sapiens)
Pain Link Frequency Relevance Heat
Angina 257 99.80 Very High Very High Very High
imagery 87 99.76 Very High Very High Very High
Percutaneous transluminal coronary angioplasty 7 92.88 High High
cva 28 91.52 High High
adenocard 9 89.52 High High
medulla 1 87.80 High High
Pain 30 84.24 Quite High
ischemia 25 80.00 Quite High
Bile 16 76.88 Quite High
aspirin 49 70.76 Quite High
Disease Link Frequency Relevance Heat
Coronary Artery Disease 2102 100.00 Very High Very High Very High
Cv Unclassified Under Development 1026 100.00 Very High Very High Very High
Nicotine Addiction 257 100.00 Very High Very High Very High
Obesity 168 100.00 Very High Very High Very High
Coronary Heart Disease 147 100.00 Very High Very High Very High
Canine Hip Dysplasia 29 100.00 Very High Very High Very High
Insulin Resistance 2 100.00 Very High Very High Very High
Impaired Glucose Tolerance 2 99.92 Very High Very High Very High
Dyslipidemia /

Combined Dyslipidemia

36 99.82 Very High Very High Very High
Cv General 3 Under Development 175 99.80 Very High Very High Very High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Furthermore, other conditions and indicators of high CHD risk such as family history of CHD, obesity, physical activity, income, education, and levels of C-reactive protein, triglycerides and Lp(a), for example, were unavailable.
Gene_expression (levels) of CHD associated with coronary artery disease and obesity
1) Confidence 0.65 Published 2004 Journal BMC Med Section Body Doc Link PMC515311 Disease Relevance 0.78 Pain Relevance 0
Initial diagnosis of CHD
Gene_expression (diagnosis) of CHD associated with coronary artery disease
2) Confidence 0.58 Published 2007 Journal BMC Fam Pract Section Body Doc Link PMC1853095 Disease Relevance 0.49 Pain Relevance 0.04
Once a CHD diagnosis is established based on the occurrence of a cardiac event such as AMI or unstable angina, there may be a greater likelihood that men receive additional testing or aggressive intervention.[7,18,32] This still leaves potential opportunities for earlier diagnosis of CHD in men that have not had an event such as unstable angina.
Gene_expression (diagnosis) of CHD associated with angina and coronary artery disease
3) Confidence 0.58 Published 2007 Journal BMC Fam Pract Section Body Doc Link PMC1853095 Disease Relevance 1.65 Pain Relevance 0.63
It is very likely her CAC score will be zero (89%) or less than 100 (10%), in which case her post-test 10-year CHD risk will still be low (?
Gene_expression (risk) of CHD associated with coronary artery disease
4) Confidence 0.56 Published 2004 Journal BMC Med Section Body Doc Link PMC515311 Disease Relevance 0.54 Pain Relevance 0.09
Unrecognized and untreated CHD risk factors were present in both men (45% of men 5 years prior to AMI) and women (22% of women 5 years prior to first AMI), more common in men and those without a diagnosis of CHD prior to incident AMI (p < 0.0001).


Gene_expression (present) of CHD
5) Confidence 0.52 Published 2007 Journal BMC Fam Pract Section Abstract Doc Link PMC1853095 Disease Relevance 0.06 Pain Relevance 0
In our search for articles about the benefits of physician knowledge of global CHD risk scores, we excluded studies for the following reasons: (1) studies were unrelated to global CHD risk calculation; (2) they calculated the risk scores for the secondary prevention of CHD risk; (3) they answered the wrong question about CHD risk scores (e.g. they were related to development and validation of risk scores; the conceptual understanding of risk scores; the accuracy of risk perception; the accuracy of systems to calculate CHD risk; or the acceptability of decision aids including CHD risk); (4) they used risk scores for the wrong use (e.g. as part of the eligibility criteria or endpoints of a study, but not as information for physicians); (5) they were about the benefits of CHD risk scores, but did not have a quantitative experimental design (e.g. reviews, editorials, qualitative studies, methods papers); (6) they used a non-controlled experimental design (e.g. pre-post designs); (7) they focused on the effects of patient knowledge of CHD risk scores; or (8) they administered global risk as part of a mixed intervention without the ability to determine the independent effect of the risk score.
Gene_expression (risk) of CHD associated with coronary artery disease and acquired immune deficiency syndrome or hiv infection
6) Confidence 0.40 Published 2008 Journal BMC Health Serv Res Section Body Doc Link PMC2294118 Disease Relevance 1.12 Pain Relevance 0.03
In aggregate, these studies suggest that giving patients global risk information in combination with individualized counseling and/or detailed group education (but not alone) may result in reductions in CHD risk factors (e.g. poor diet, physical inactivity, obesity, and smoking) and CHD risk.
Gene_expression (risk) of CHD associated with nicotine addiction, coronary artery disease and obesity
7) Confidence 0.40 Published 2008 Journal BMC Health Serv Res Section Body Doc Link PMC2294118 Disease Relevance 0.57 Pain Relevance 0
In our search for articles about the benefits of physician knowledge of global CHD risk scores, we excluded studies for the following reasons: (1) studies were unrelated to global CHD risk calculation; (2) they calculated the risk scores for the secondary prevention of CHD risk; (3) they answered the wrong question about CHD risk scores (e.g. they were related to development and validation of risk scores; the conceptual understanding of risk scores; the accuracy of risk perception; the accuracy of systems to calculate CHD risk; or the acceptability of decision aids including CHD risk); (4) they used risk scores for the wrong use (e.g. as part of the eligibility criteria or endpoints of a study, but not as information for physicians); (5) they were about the benefits of CHD risk scores, but did not have a quantitative experimental design (e.g. reviews, editorials, qualitative studies, methods papers); (6) they used a non-controlled experimental design (e.g. pre-post designs); (7) they focused on the effects of patient knowledge of CHD risk scores; or (8) they administered global risk as part of a mixed intervention without the ability to determine the independent effect of the risk score.
Gene_expression (risk) of CHD associated with coronary artery disease and acquired immune deficiency syndrome or hiv infection
8) Confidence 0.40 Published 2008 Journal BMC Health Serv Res Section Body Doc Link PMC2294118 Disease Relevance 1.00 Pain Relevance 0.03
In our search for articles about the benefits of physician knowledge of global CHD risk scores, we excluded studies for the following reasons: (1) studies were unrelated to global CHD risk calculation; (2) they calculated the risk scores for the secondary prevention of CHD risk; (3) they answered the wrong question about CHD risk scores (e.g. they were related to development and validation of risk scores; the conceptual understanding of risk scores; the accuracy of risk perception; the accuracy of systems to calculate CHD risk; or the acceptability of decision aids including CHD risk); (4) they used risk scores for the wrong use (e.g. as part of the eligibility criteria or endpoints of a study, but not as information for physicians); (5) they were about the benefits of CHD risk scores, but did not have a quantitative experimental design (e.g. reviews, editorials, qualitative studies, methods papers); (6) they used a non-controlled experimental design (e.g. pre-post designs); (7) they focused on the effects of patient knowledge of CHD risk scores; or (8) they administered global risk as part of a mixed intervention without the ability to determine the independent effect of the risk score.
Gene_expression (scores) of CHD associated with coronary artery disease and acquired immune deficiency syndrome or hiv infection
9) Confidence 0.40 Published 2008 Journal BMC Health Serv Res Section Body Doc Link PMC2294118 Disease Relevance 1.12 Pain Relevance 0.03
Changes in CHD risk factors and global CHD risk
Gene_expression (risk) of CHD associated with coronary artery disease
10) Confidence 0.40 Published 2008 Journal BMC Health Serv Res Section Body Doc Link PMC2294118 Disease Relevance 0.75 Pain Relevance 0
Changes in CHD events
Gene_expression (events) of CHD associated with coronary artery disease
11) Confidence 0.40 Published 2008 Journal BMC Health Serv Res Section Body Doc Link PMC2294118 Disease Relevance 0.91 Pain Relevance 0
The harms of CHD risk calculation
Gene_expression (risk) of CHD associated with coronary artery disease
12) Confidence 0.40 Published 2008 Journal BMC Health Serv Res Section Body Doc Link PMC2294118 Disease Relevance 0.87 Pain Relevance 0
In aggregate, these studies suggest that giving patients global risk information in combination with individualized counseling and/or detailed group education (but not alone) may result in reductions in CHD risk factors (e.g. poor diet, physical inactivity, obesity, and smoking) and CHD risk.
Gene_expression (risk) of CHD associated with nicotine addiction, coronary artery disease and obesity
13) Confidence 0.40 Published 2008 Journal BMC Health Serv Res Section Body Doc Link PMC2294118 Disease Relevance 0.64 Pain Relevance 0
Changes in CHD risk factors and global CHD risk
Gene_expression (risk) of CHD associated with coronary artery disease
14) Confidence 0.40 Published 2008 Journal BMC Health Serv Res Section Body Doc Link PMC2294118 Disease Relevance 0.75 Pain Relevance 0
To understand each side in the argument, the metabolism/transport of cholesterol and lipoproteins in dyslipidemia and its effect on CHD, as well as different therapeutic targets, including current and future drug therapies, will be discussed.


Gene_expression (effect) of CHD associated with coronary artery disease
15) Confidence 0.37 Published 2010 Journal Vascular Health and Risk Management Section Body Doc Link PMC2835557 Disease Relevance 0.67 Pain Relevance 0.04
A seventh “coronary heart disease” was inserted, then its abbreviation “CHD” and four conditions related to it and their abbreviations, where appropriate, all as separate keywords: “myocardial infarction,” “MI,” “coronary artery bypass graft,” “CABG,” “percutaneous transluminal coronary angioplasty,” “PTCA,” and “angina pectoris
Gene_expression (then) of CHD in coronary artery associated with cva, coronary heart disease, myocardial infarction and percutaneous transluminal coronary angioplasty
16) Confidence 0.31 Published 2011 Journal Cardiology Research and Practice Section Body Doc Link PMC3010651 Disease Relevance 0.56 Pain Relevance 0.14
No significant differences in the main outcome parameter, when accounting for the actual treatment given, were detected for CHD (p = 0.25) or body weight (p = 0.44).
Gene_expression (detected) of CHD in body associated with body weight and canine hip dysplasia
17) Confidence 0.28 Published 2005 Journal Acta Vet Scand Section Body Doc Link PMC2202790 Disease Relevance 0.90 Pain Relevance 0.33
Licht found PVL in 28% of CHD patients imaged with MRI preoperatively [15].
Gene_expression (imaged) of CHD associated with coronary heart disease, imagery and periventricular leukomalacia
18) Confidence 0.28 Published 2010 Journal International Journal of Pediatrics Section Body Doc Link PMC2938447 Disease Relevance 2.20 Pain Relevance 0.35
However, the association between CRP genotype and CHD has not been confirmed by other studies or meta-analyses [19], [25], [27].
Gene_expression (genotype) of CHD associated with coronary artery disease
19) Confidence 0.25 Published 2008 Journal PLoS ONE Section Body Doc Link PMC2507732 Disease Relevance 1.02 Pain Relevance 0
Association of CRP levels and CHD
Gene_expression (levels) of CHD associated with cv unclassified under development
20) Confidence 0.23 Published 2008 Journal PLoS ONE Section Body Doc Link PMC2507759 Disease Relevance 0.92 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox